The burden of respiratory syncytial virus infection in young children
- PMID: 19196675
- PMCID: PMC4829966
- DOI: 10.1056/NEJMoa0804877
The burden of respiratory syncytial virus infection in young children
Abstract
Background: The primary role of respiratory syncytial virus (RSV) in causing infant hospitalizations is well recognized, but the total burden of RSV infection among young children remains poorly defined.
Methods: We conducted prospective, population-based surveillance of acute respiratory infections among children under 5 years of age in three U.S. counties. We enrolled hospitalized children from 2000 through 2004 and children presenting as outpatients in emergency departments and pediatric offices from 2002 through 2004. RSV was detected by culture and reverse-transcriptase polymerase chain reaction. Clinical information was obtained from parents and medical records. We calculated population-based rates of hospitalization associated with RSV infection and estimated the rates of RSV-associated outpatient visits.
Results: Among 5067 children enrolled in the study, 919 (18%) had RSV infections. Overall, RSV was associated with 20% of hospitalizations, 18% of emergency department visits, and 15% of office visits for acute respiratory infections from November through April. Average annual hospitalization rates were 17 per 1000 children under 6 months of age and 3 per 1000 children under 5 years of age. Most of the children had no coexisting illnesses. Only prematurity and a young age were independent risk factors for hospitalization. Estimated rates of RSV-associated office visits among children under 5 years of age were three times those in emergency departments. Outpatients had moderately severe RSV-associated illness, but few of the illnesses (3%) were diagnosed as being caused by RSV.
Conclusions: RSV infection is associated with substantial morbidity in U.S. children in both inpatient and outpatient settings. Most children with RSV infection were previously healthy, suggesting that control strategies targeting only high-risk children will have a limited effect on the total disease burden of RSV infection.
2009 Massachusetts Medical Society
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4829966/bin/nihms763002f1.gif)
![Figure 2](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/4829966/bin/nihms763002f2.gif)
Similar articles
-
Population-based surveillance for hospitalizations associated with respiratory syncytial virus, influenza virus, and parainfluenza viruses among young children.Pediatrics. 2004 Jun;113(6):1758-64. doi: 10.1542/peds.113.6.1758. Pediatrics. 2004. PMID: 15173503
-
Risk factors of respiratory syncytial virus infection among pediatric influenza-like illness and severe acute respiratory infections in Suzhou, China.J Med Virol. 2018 Mar;90(3):397-404. doi: 10.1002/jmv.24961. Epub 2017 Nov 9. J Med Virol. 2018. PMID: 28975651
-
Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006.Pediatr Infect Dis J. 2012 Jan;31(1):5-9. doi: 10.1097/INF.0b013e31822e68e6. Pediatr Infect Dis J. 2012. PMID: 21817948
-
Risk factors for respiratory syncytial virus associated with acute lower respiratory infection in children under five years: Systematic review and meta-analysis.J Glob Health. 2015 Dec;5(2):020416. doi: 10.7189/jogh.05.020416. J Glob Health. 2015. PMID: 26682048 Free PMC article. Review.
-
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis.Lancet. 2022 May 28;399(10340):2047-2064. doi: 10.1016/S0140-6736(22)00478-0. Epub 2022 May 19. Lancet. 2022. PMID: 35598608 Free PMC article. Review.
Cited by
-
Structure-Based Discovery of Allosteric Inhibitors Targeting a New Druggable Site in the Respiratory Syncytial Virus Polymerase.ACS Omega. 2024 May 6;9(20):22213-22229. doi: 10.1021/acsomega.4c01207. eCollection 2024 May 21. ACS Omega. 2024. PMID: 38799318 Free PMC article.
-
Safety and Efficacy of Nirsevimab in a Universal Prevention Program of Respiratory Syncytial Virus Bronchiolitis in Newborns and Infants in the First Year of Life in the Valle d'Aosta Region, Italy, in the 2023-2024 Epidemic Season.Vaccines (Basel). 2024 May 17;12(5):549. doi: 10.3390/vaccines12050549. Vaccines (Basel). 2024. PMID: 38793800 Free PMC article.
-
Epidemiology of Respiratory Syncytial Virus Hospitalizations in Poland: An Analysis from 2015 to 2023 Covering the Entire Polish Population of Children Aged under Five Years.Viruses. 2024 Apr 29;16(5):704. doi: 10.3390/v16050704. Viruses. 2024. PMID: 38793586 Free PMC article.
-
Viral load in hospitalized infants with respiratory syncytial virus bronchiolitis: a three-way comparative analysis.Eur J Pediatr. 2024 Aug;183(8):3471-3478. doi: 10.1007/s00431-024-05614-3. Epub 2024 May 23. Eur J Pediatr. 2024. PMID: 38780651
-
Global Seasonal Activities of Respiratory Syncytial Virus Before the Coronavirus Disease 2019 Pandemic: A Systematic Review.Open Forum Infect Dis. 2024 Apr 25;11(5):ofae238. doi: 10.1093/ofid/ofae238. eCollection 2024 May. Open Forum Infect Dis. 2024. PMID: 38770210 Free PMC article. Review.
References
-
- Bethesda, MD: National Institute of Allergy and Infectious Diseases; 2002. [Accessed January 12, 2009]. The Jordan Report: accelerated development of vaccines 2002. at http://www3.niaid.nih.gov/topics/Malaria/PDF/jordan20_2002.pdf.
-
- Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med. 2001;344:1917–1928. - PubMed
-
- Boyce TG, Mellen BG, Mitchel EF, Jr, Wright PF, Griffin MR. Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid. J Pediatr. 2000;137:865–870. - PubMed
-
- Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980–1996. JAMA. 1999;282:1440–1446. - PubMed
-
- Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr. 2003;143(Suppl):S127–S132. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous